Published on 30 Dec 2024 on Investing.com
Emergent BioSolutions stock leverages NARCAN and vaccine sales for long-term...
Monday, H.C. Wainwright began covering Emergent BioSolutions Inc. (NYSE:EBS) with a Buy rating and a...
NASDAQ.AZN price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free